论文部分内容阅读
探索局部应用皮质类固醇激素以降低其全身不良反应的研究始于上世纪中叶,1972年英国首先研制了二丙酸倍氯米松(Beclomethasone Dipropionate,BDP),通过定量雾化器(metered dose inhaler,MDI)吸入治疗哮喘取得了很好的
The study of topical application of corticosteroids to reduce the systemic adverse reactions began in the middle of the last century. In 1972, Beclomethasone Dipropionate (BDP) was first developed in the UK and administered via metered dose inhaler (MDI) Inhaled asthma has made good progress